Over longer periods (3-4 weeks to a month), more visible changes in body composition (lean mass gains, fat loss) and energy tend to emerge
Composition & Format Peptide: CJC-1295 With DAC Strength options: 2 mg or 5 mg per vial (variable product) Kit configuration: 10 vials/kit 20 mg or 50 mg total peptide per kit Form: white lyophilized peptide powder in crimp-sealed vials Origin: China-based peptide factory with OEM and bulk supply capability Key Features for Wholesale Buyers High-purity (99%) CJC-1295 DAC suitable for advanced peptide research panels Factory-direct supply from a specialised peptide manufacturer in China Stable lyophilized format for international shipping and long-term storage Flexible order structure: standard 10-vial kits, with bulk and OEM packing on request Technical documents (COA / HPLC data) can be provided for qualifying bulk orders Packaging & Ordering Standard packaging: 10 vials packed in hard plastic trays with protective outer packing Cartons prepared for export with foam or bubble-wrap to reduce transport damage China-based factory support for wholesale, bulk and OEM relabel projects For pricing, MOQ and custom label options, please contact us directly for a quotation Order processing and dispatch updates are typically provided within 3 business days after payment confirmation Storage & Handling Recommended storage: 28 C in a clean, dry environment, protected from light For longer-term storage, many labs store lyophilized vials in a freezer to maximise stability Reconstituted solutions should be handled using appropriate aseptic techniques under local laboratory guidelines Related Products CJC-1295 Without DAC single peptide kit CJC-1295 (No DAC) 5 mg + Ipamorelin 5 mg combo GHRH/GHRP peptide kit Ipamorelin GH secretagogue peptide kit TB-500 healing & recovery peptide kit BPC-157 tissue-repair peptide kit THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY
The Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit
Nature (2000) 405(6790):106973.10.1038/35016611 126 StarrRWillsonTAVineyEMMurrayLJRaynerJRJenkinsBJet alA family of cytokine-inducible inhibitors of signalling
This dynamic duo has demonstrated its ability to reduce visceral adipose tissue (VAT) and lower triglyceride levels
